IDOR-1134-9712

N/A

Report date: 2025/02/17 14:16:56
NME

Base Information

Drug NameIDOR-1134-9712
Drug Alias NameIDOR-1134-9712
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCystic fibrosis transmembrane conductance regulator modulators
TargetsCystic fibrosis transmembrane conductance regulator
Therapy Area/IndicationsCystic Fibrosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwitzerland
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesIdorsia Pharmaceuticals Ltd
China Registration ClassN/A

Develop Information

Active CompaniesIdorsia Pharmaceuticals Ltd
Inactive CompaniesN/A
Active IndicationsCystic Fibrosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A